19th Mar 2015 09:40
LONDON (Alliance News) - Cyprotex PLC on Thursday said it has launched a Short Time Exposure in-vitro testing service, an assay test developed for identifying potentially serious eye damage from new chemicals rather than the current method of testing on rabbit eyes.
"The addition of the new STE service enables Cyprotex to test chemicals for potentially harmful ocular effects. By bringing this on board we comply with new regulatory guidance and are well placed to meet the needs of our customers for non-animal alternative testing," said Cyprotex Chief Executive Officer Anthony Baxter.
Shares in Cyprotex were untraded Thursday, having last traded at 59.00 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
CRX.L